Can lamotrigine cause itching?

Yes, lamotrigine can cause itching, and this is an important warning sign that requires immediate attention.

Itching (pruritus) associated with lamotrigine is a significant clinical concern because it often accompanies or precedes serious, potentially life-threatening cutaneous reactions including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). 1, 2

Clinical Presentation

The itching typically presents as:

• Pruritic (itchy) full-body rash that can involve the palms and soles 1
• Often accompanied by erythematous (red) skin changes
• May start with bumps on the lips spreading to oral mucosa 1
• Usually develops within the first 4-8 weeks of treatment, though can occur even after years of stable therapy 3

Critical Action Required

Discontinue lamotrigine immediately at the first sign of rash or itching. This is non-negotiable. The case reports demonstrate that even with appropriate dosing and titration, serious cutaneous reactions can develop 1, 2.

Red Flags for Serious Reactions:

• Itching accompanied by any rash
• Fever or feeling feverish
• Oral mucosal involvement
• Involvement of palms and soles
• Facial or periorbital swelling
• Blistering or skin pain

Management of Itching

If itching occurs:

1. Stop lamotrigine immediately - do not wait to see if it worsens
2. Assess for accompanying rash or systemic symptoms
3. Consider dermatology consultation if any rash present
4. Symptomatic treatment may include:
   • H1-antihistamines (e.g., hydroxyzine) 1
   • Topical corticosteroids for mild cases
   • Systemic corticosteroids (prednisone 40 mg) for confirmed serious reactions 1

Risk Factors

Higher risk occurs with:

• Rapid dose titration
• Concomitant valproic acid use (increases lamotrigine levels)
• Concomitant flunitrazepam use (newly identified risk factor that increases lamotrigine concentrations) 4
• Female patients, particularly postpartum 2
• Asian ethnicity (HLA-B*1502 association) 2
• Rechallenge within 4 weeks of initial rash (36% recurrence rate) 5

Common Pitfall

Do not dismiss mild itching as a benign side effect. While the overall incidence of serious rash is relatively low (4% reported rash, 2% requiring withdrawal in long-term studies 6), the consequences of missing early SJS/TEN are catastrophic. The mortality risk increases significantly if the drug is not stopped promptly.

Rechallenge Considerations

If lamotrigine was highly effective and the initial rash was benign (no signs of seriousness), rechallenge may be considered but:

• Wait at least 4 weeks after resolution 5
• Use very slow titration (5 mg every other day initially) 5
• Success rate is 85% overall, but only if the initial rash had no serious features 5
• Never rechallenge if there were 3 or more signs of serious rash 5